Nevirapine
Generics; previously available as Viramune, Viramune XR; NVP
Antiviral, nonnucleoside reverse transcriptase inhibitor
| B | 2 | Yes | Yes | No |
| Key |
- Tabs: 200 mg
- Extended release tabs: 100, 400 mg
- Oral suspension: 10 mg/mL (240 mL); contains parabens, propylene glycol, and polysorbate 80
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Nevirapine." Harriet Lane Handbook Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309713/0/Nevirapine.
Nevirapine. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309713/0/Nevirapine. Accessed September 29, 2026.
Nevirapine. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309713/0/Nevirapine
Nevirapine [Internet]. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook Harriet Lane Handbook. Elsevier; 2024. [cited 2026 September 29]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309713/0/Nevirapine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nevirapine
ID - 309713
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309713/0/Nevirapine
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -

Harriet Lane Handbook

